Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 2;16(1):e51530.
doi: 10.7759/cureus.51530. eCollection 2024 Jan.

Depression and Anxiety in Patients With Polycystic Ovary Syndrome: A Cross-Sectional Study in Saudi Arabia

Latteefah Alnaeem  1 , Muntaha Alnasser  2 , Yaqin AlAli  2 , Fatimah Almarri  2 , Abdulmuhsin A Al Sultan  2 , Fatimah A Almuhaysin  2 , Nadeen A Boubshait  2 , Latifah A Almulhim  2
Affiliations

Depression and Anxiety in Patients With Polycystic Ovary Syndrome: A Cross-Sectional Study in Saudi Arabia

Latteefah Alnaeem et al. Cureus. .

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females of childbearing age. It causes irregular menstruation, infertility, acne vulgaris, androgenic alopecia, and hirsutism. It is associated with a higher risk of mental disorders. This study aimed to determine the prevalence of depression and anxiety among females with PCOS and the factors associated with these disorders.

Methods: This cross-sectional study was conducted between 15th January and 19th November 2023. We invited Saudi women to do an online survey. We sent the survey link privately, got their permission, and explained the research to ensure privacy and reliability. Females with a previous psychiatric history were excluded. Depression, Anxiety, and Stress Scale-21 Items (DASS-21) were used to assess depression, anxiety, and distress. One-way analysis of variance (ANOVA) and two-sample t-tests were used to identify determinants of depression and anxiety.

Results: About 967 females participated, of whom 474 (49%) were married, and 358 (37%) had a healthy weight. About 367 (37.9%) of participants were diagnosed with PCOS, and it was associated with age (26-35 years), divorce, and family history of PCOS (p < 0.05). About 112 (30.5%) of PCOS patients experienced extremely severe depression, and 144 (39.2%) had extreme anxiety. People in the age range of 15-25 years had a higher risk of depression and stress (p < 0.05). Divorced participants faced a higher risk of depression, anxiety, and stress than singles (p < 0.05). Those advised on diet and healthy lifestyles exhibited a higher risk of depression, anxiety, and stress than those who were not (p < 0.05). Additionally, being overweight was associated with a higher risk of depression (p < 0.05).

Conclusion: The prevalence of PCOS was found to be 37.9% in our study, which may seem higher compared to the existing literature on PCOS. It is associated with being in the age group of 26-35 years, being divorced, and having a positive family history. Almost two-thirds of females with PCOS had depression, anxiety, and stress. Factors associated with the three disorders include divorce and management with diet and lifestyle modifications. Depression and stress were associated with young age. High body mass index (BMI) was associated with depression.

Keywords: anxiety; depression; middle east; polycystic ovary syndrome; stress.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Psychological well-being dimensions
Figure 2
Figure 2. Ethical approval letter
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Clinical practice guidelines on the diagnosis and management of polycystic ovary syndrome: a systematic review and quality assessment study. Al Wattar BH, Fisher M, Bevington L, Talaulikar V, Davies M, Conway G, Yasmin E. J Clin Endocrinol Metab. 2021;106:2436–2446. - PMC - PubMed
    1. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Teede HJ, Tay CT, Laven JJ, et al. https://doi.org/10.1093/ejendo/lvad096 Eur J Endocrinol. 2023;189:0–64. - PubMed
    1. The prevalence of polycystic ovary syndrome: a brief systematic review. Deswal R, Narwal V, Dang A, Pundir CS. J Hum Reprod Sci. 2020;13:261–271. - PMC - PubMed
    1. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Lim SS, Kakoly NS, Tan JW, et al. https://pubmed.ncbi.nlm.nih.gov/30339316/ Obes Rev. 2019;20:339–352. - PubMed
    1. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Sadeghi HM, Adeli I, Calina D, et al. Int J Mol Sci. 2022;23:583. - PMC - PubMed

LinkOut - more resources